Using the data from Kaplan Meier plotter and LOGpc, we noted that leiomyosarcoma patients who had an association of genomic alterations in CDK4, CCT2, and MGAT1 showed reductions in overall and disease-free survival. Here, CCT2 is linked to leiomyosarcoma.